We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KSPI:NASDAQJoint Stock Company Kaspi.kz - American Depository Shares Analysis

Data as of 2026-08-02 - not real-time

$88.78

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kaspi.kz (KSPI) is trading at $88.78, comfortably above its 20‑day ($88.01) and 50‑day ($86.95) simple moving averages, indicating short‑term bullish momentum, while the 14‑day RSI of 55 suggests the stock is neither overbought nor oversold. Technical signals are mixed – the MACD histogram is negative and the MACD line sits below its signal line, flagging a bearish tilt, yet the overall trend remains bullish with price well above the 200‑day SMA of $79.71. The valuation is exceptionally cheap: a trailing P/E of 7.83 versus an industry average of 32.80 and a price‑to‑book of 0.0075, implying the market may be undervaluing the firm’s assets. Fundamentally, revenue is growing at 31.3% YoY, profit margins are robust at 24.9%, and ROE is a striking 46.7%, but the balance sheet raises concerns – debt‑to‑equity stands at 11.86, free cash flow is strongly negative, and total cash is zero, questioning cash‑flow sustainability. The dividend yield of 4.04% is attractive, yet a payout ratio of 0% and the cash‑flow deficit suggest the dividend may not be fully sustainable. Volatility is high at ~25% over the past 30 days and beta of 1.12 points to greater sensitivity to market swings, while the max drawdown of 29.5% underscores downside risk. Recent material news – regulatory approval and completion of the acquisition of Rabobank A.Ş. in Turkey – expands the company’s geographic footprint and could unlock new revenue streams, providing a catalyst for upside. The current price sits near the identified support level of $84.46 with resistance at $92.28, offering a modest upside of roughly 9.8% to the target median price of $92.84. Overall, the stock presents a compelling value case tempered by balance‑sheet and macro‑risk considerations.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Recent acquisition of Rabobank A.Ş. expanding into Turkey
  • Attractive 4.04% dividend yield despite sustainability concerns
  • Price positioned near support with upside to resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (31.3% YoY) and high profit margins
  • Undervalued multiples (P/E 7.8 vs industry 32.8, P/B 0.0075)
  • Integration benefits from the Turkish banking acquisition

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity and negative free cash flow
  • Exposure to emerging‑market geopolitical and currency risks
  • Sustained high ROE and potential for continued fintech expansion

Key Metrics & Analysis

Financial Health

Revenue Growth31.30%
Profit Margin24.91%
P/E Ratio7.8
ROE46.75%
ROA14.30%
Debt/Equity11.86
P/B Ratio0.0
Free Cash Flow$-736221528064
Industry P/E32.8

Technical Analysis

TrendBullish
RSI55.2
Support$84.46
Resistance$92.28
MA 20$88.01
MA 50$86.95
MA 200$79.71
MACDBearish
VolumeStable
Fear & Greed Index92.88

Valuation

Target Price$97.45
Upside/Downside9.76%
GradeUndervalued
TypeBlend
Dividend Yield4.04%

Risk Assessment

Beta1.12
Volatility24.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.